We selected the differential gene FLNA, which was significantly different in lung cancer patients when compared with healthy subjects by analysis via the Platelet Expression Atlas website, to verify the differential expression of the FLNA in the platelets of lung cancer and healthy subjects by using GAPDH as the reference gene. The gene discussed is GAPDH; the disease is lung carcinoma.